Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions - PubMed (original) (raw)
. 2018 Feb 23;50(2):e450.
doi: 10.1038/emm.2017.282.
Youngwoo Choi 2, Dae-Kyum Kim 1, Hyun T Park 2, Jaewang Ghim 3, Yonghoon Kwon 2, Jinseong Jeon 2, Min-Seon Kim 4, Young-Koo Jee 5, Yong S Gho 2, Hae-Sim Park 6, Yoon-Keun Kim 7, Sung H Ryu 1 2
Affiliations
- PMID: 29472701
- PMCID: PMC5903829
- DOI: 10.1038/emm.2017.282
Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions
Chaithanya Chelakkot et al. Exp Mol Med. 2018.
Abstract
The gut microbiota has an important role in the gut barrier, inflammation and metabolic functions. Studies have identified a close association between the intestinal barrier and metabolic diseases, including obesity and type 2 diabetes (T2D). Recently, Akkermansia muciniphila has been reported as a beneficial bacterium that reduces gut barrier disruption and insulin resistance. Here we evaluated the role of A. muciniphila-derived extracellular vesicles (AmEVs) in the regulation of gut permeability. We found that there are more AmEVs in the fecal samples of healthy controls compared with those of patients with T2D. In addition, AmEV administration enhanced tight junction function, reduced body weight gain and improved glucose tolerance in high-fat diet (HFD)-induced diabetic mice. To test the direct effect of AmEVs on human epithelial cells, cultured Caco-2 cells were treated with these vesicles. AmEVs decreased the gut permeability of lipopolysaccharide-treated Caco-2 cells, whereas Escherichia coli-derived EVs had no significant effect. Interestingly, the expression of occludin was increased by AmEV treatment. Overall, these results imply that AmEVs may act as a functional moiety for controlling gut permeability and that the regulation of intestinal barrier integrity can improve metabolic functions in HFD-fed mice.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Figure 1
Microbial diversity and relative abundances of EVs in human feces. Metagenomic data showing microbial diversity. (a) Microbial diversity in the feces of type 2 diabetic patients and healthy controls. (b) Microbial diversity in the fecal EVs of type 2 diabetic patients and healthy controls. (c) Heat map of normalized EV contents. Only species that showed significant differences were used to draw this heat map (P<0.05). The order of species was sorted by the content ratio (type 2 diabetes patients over healthy controls), showing that A. muciniphila might be a candidate EV-secreting bacterium that suppresses type 2 diabetes.
Figure 2
In vivo distribution of Cy7-labeled _A. muciniphila_-derived EVs in mice. Cy7-labeled AmEVs (50 μg of total protein) were orally administered to C57BL/6 mice. (a) In vivo fluorescent whole-body images of AmEVs in mice were acquired with an IVIS spectrum. (b) Ex vivo image of various tissues, including liver, fat, muscle, pancreas, spleen and large intestine, after 6 h of EV feeding. (c) Radiant efficiency was measured using the Living Image 3.1 software. All data are presented as the mean±s.e.m. of 3 experiments, with _n_=5–7 animals per group for each experiment. *P<0.05.
Figure 3
_A. muciniphila_-derived EVs improve gut permeability in high-fat diet (HFD)-fed mice. Mice were fed a normal chow diet (NCD) or a HFD for 12 weeks, followed by oral administration of AmEVs (10 μg per mouse) every other day for 2 weeks. (a) Body weight changes were measured at the indicated time points. The graph shows body weight change from the day that EV feeding started. (b) In vivo intestinal permeability assay in NCD, NCD+AmEV, HFD and HFD+AmEV mice conducted after 4 h of treatment with FITC-dextran. The serum FITC concentration was measured using blood collected by retro-orbital bleeding, and fluorescence was measured using a spectrofluorometer. Data are shown as the mean±s.e.m. (c) Gross imaging of the colons dissected from NCD-, NCD+AmEV-, HFD- and HFD+AmEV-fed mice. (d) The colon length of NCD-, NCD+AmEV-, HFD- and HFD+AmEV-fed mice. (e) Hematoxylin and eosin staining of colon sections from NCD-, NCD+AmEV-, HFD- and HFD+AmEV-fed mice. Red arrows indicate the recruitment of immune cells. Scale bar is 50 μm. (f) Immunohistochemical images showing occludin expression (occludin—red, nucleus—blue) in NCD-, NCD+AmEV-, HFD- and HFD+AmEV-fed mice. Scale bar is 50 μm. All data are presented as the mean±s.e.m. of 3 experiments; _n_=5–7 per group; *P<0.05, **P<0.01.
Figure 4
_A. muciniphila_-derived EVs reduce LPS-induced intestinal permeability through AMPK phosphorylation. (a) Trans-epithelial electrical resistance in Caco-2 cells 4 h after treatment with LPS (5 μg ml−1), LPS (5 μg ml−1)+EcEVs (1 μg ml−1) and LPS (5 μg ml−1)+AmEVs (1 μg ml−1). (b) In vitro permeability assay in Caco-2 cells 4 h after LPS (5 μg ml−1), LPS (5 μg ml−1)+EcEV (1 μg ml−1) and LPS (5 μg ml−1)+AmEV (1 μg ml−1) treatment. FITC-dextran was added to the upper chamber in the Caco-2 transwell chamber assay, and the transport of FITC-labeled dextran across the Caco-2 monolayer culture was measured by fluorescence spectrofluorometry. (c) Expression of tight junction proteins in Caco-2 cells after LPS, LPS+EcEV and LPS+AmEV treatments. A graph showing the relative occludin expression (normalized to actin) is also shown (*P<0.05). (d) AmEV treatment increased occludin expression and phosphorylation of AMPKα2 thr-172 in a dose-dependent manner. Caco-2 cells were treated with 0.1, 1 and 10 μg ml−1 AmEVs, and the expression of occludin, p-AMPK, total AMPK and actin was analyzed after 4 h by immunoblotting. A graph showing the relative protein expression normalized to actin is shown (occludin expression in NT vs the specified treatment group ##P<0.01, ###P<0.001; p-AMPK expression in NT vs the specified treatment group **P<0.01). (e) Time course of AmEV-induced occludin and p-AMPK expression in Caco-2 cells. Caco-2 cells were treated with 1 μg ml−1 AmEVs, and the expression of occludin, p-AMPK, total AMPK and actin was analyzed after 1, 2, 4 and 8 h by immunoblotting. The graph shows the relative protein expression after normalization to actin (occludin expression in NT vs the specified time point #P<0.05; p-AMPK expression in NT vs the specified time point *P<0.05, **P<0.01). (f) Western blot showing the effect of the AMPK inhibitor on AmEV-treated Caco-2 cells. Caco-2 cells were treated with the AMPK-specific inhibitor compound C for 30 min, after which 1 μg ml−1 AmEVs was applied. Protein expression of occludin and p-AMPK was observed after 4 h. The graph shows the relative occludin expression after normalization to actin (occludin expression in NT vs the specified time point #P<0.05). All data are presented as the mean±s.e.m. of three experiments performed in triplicate. NS, not significant.
Similar articles
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD. Everard A, et al. Proc Natl Acad Sci U S A. 2013 May 28;110(22):9066-71. doi: 10.1073/pnas.1219451110. Epub 2013 May 13. Proc Natl Acad Sci U S A. 2013. PMID: 23671105 Free PMC article. - Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe-/- mice.
Zhu L, Zhang D, Zhu H, Zhu J, Weng S, Dong L, Liu T, Hu Y, Shen X. Zhu L, et al. Atherosclerosis. 2018 Jan;268:117-126. doi: 10.1016/j.atherosclerosis.2017.11.023. Epub 2017 Nov 24. Atherosclerosis. 2018. PMID: 29202334 - Navy bean supplemented high-fat diet improves intestinal health, epithelial barrier integrity and critical aspects of the obese inflammatory phenotype.
Monk JM, Wu W, Lepp D, Wellings HR, Hutchinson AL, Liddle DM, Graf D, Pauls KP, Robinson LE, Power KA. Monk JM, et al. J Nutr Biochem. 2019 Aug;70:91-104. doi: 10.1016/j.jnutbio.2019.04.009. Epub 2019 May 10. J Nutr Biochem. 2019. PMID: 31195365 - Effects of gut microbiota-derived extracellular vesicles on obesity and diabetes and their potential modulation through diet.
Díez-Sainz E, Milagro FI, Riezu-Boj JI, Lorente-Cebrián S. Díez-Sainz E, et al. J Physiol Biochem. 2022 May;78(2):485-499. doi: 10.1007/s13105-021-00837-6. Epub 2021 Sep 2. J Physiol Biochem. 2022. PMID: 34472032 Free PMC article. Review. - Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders.
Macchione IG, Lopetuso LR, Ianiro G, Napoli M, Gibiino G, Rizzatti G, Petito V, Gasbarrini A, Scaldaferri F. Macchione IG, et al. Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):8075-8083. doi: 10.26355/eurrev_201909_19024. Eur Rev Med Pharmacol Sci. 2019. PMID: 31599433 Review.
Cited by
- Akkermansia muciniphila: biology, microbial ecology, host interactions and therapeutic potential.
Ioannou A, Berkhout MD, Geerlings SY, Belzer C. Ioannou A, et al. Nat Rev Microbiol. 2024 Oct 15. doi: 10.1038/s41579-024-01106-1. Online ahead of print. Nat Rev Microbiol. 2024. PMID: 39406893 Review. - The emerging role of bacterial extracellular vesicles in human cancers.
Liang A, Korani L, Yeung CLS, Tey SK, Yam JWP. Liang A, et al. J Extracell Vesicles. 2024 Oct;13(10):e12521. doi: 10.1002/jev2.12521. J Extracell Vesicles. 2024. PMID: 39377479 Free PMC article. Review. - Appraisal of postbiotics in cancer therapy.
Sudaarsan ASK, Ghosh AR. Sudaarsan ASK, et al. Front Pharmacol. 2024 Sep 20;15:1436021. doi: 10.3389/fphar.2024.1436021. eCollection 2024. Front Pharmacol. 2024. PMID: 39372197 Free PMC article. Review. - Bacterial extracellular vesicles at the interface of gut microbiota and immunity.
Melo-Marques I, Cardoso SM, Empadinhas N. Melo-Marques I, et al. Gut Microbes. 2024 Jan-Dec;16(1):2396494. doi: 10.1080/19490976.2024.2396494. Epub 2024 Sep 28. Gut Microbes. 2024. PMID: 39340209 Free PMC article. Review. - Yoyo Dieting, Post-Obesity Weight Loss, and Their Relationship with Gut Health.
Phuong-Nguyen K, McGee SL, Aston-Mourney K, Mcneill BA, Mahmood MQ, Rivera LR. Phuong-Nguyen K, et al. Nutrients. 2024 Sep 19;16(18):3170. doi: 10.3390/nu16183170. Nutrients. 2024. PMID: 39339770 Free PMC article. Review.
References
- Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761–1772. - PubMed
- Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012; 18: 363–374. - PubMed
- Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008; 88: 894–899. - PubMed
- Karlsson CL, Onnerfalt J, Xu J, Molin G, Ahrne S, Thorngren-Jerneck K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) 2012; 20: 2257–2261. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources